KINGSWAY Corp 8-K

What Happened

• KINGSWAY Corporation (KWY) filed an 8-K on May 21, 2026 reporting results from its May 18, 2026 annual meeting of stockholders. A total of 21,157,092 shares (about 73.09% of outstanding voting shares) were represented.
• All board nominees were elected. The meeting also ratified Plante & Moran, PLLC as the independent registered public accounting firm for 2026, approved an amendment to change the corporation’s name, approved an increase to the Company’s 2020 Equity Incentive Plan share reserve, and passed a non‑binding advisory vote on executive compensation.

Key Details

• Shares represented: 21,157,092 (≈73.09% of outstanding common stock).
• Director votes (For / Withheld; broker non-votes = 6,206,576 for each):
  • John T. Fitzgerald: 14,884,242 / 66,274
  • Gregory P. Hannon: 11,413,470 / 3,537,046
  • Joshua S. Horowitz: 14,878,321 / 72,195
  • Terence M. Kavanagh: 13,072,821 / 1,877,695
  • Douglas Levine: 13,100,535 / 1,849,981
  • Adam J. Patinkin: 14,888,689 / 61,827
  • Corissa B. Porcelli: 13,101,937 / 1,848,579
  • Joseph D. Stilwell: 11,577,505 / 3,373,011
• Proposal vote totals:
  • Auditor ratification (Plante & Moran): For 21,121,851; Against 34,074; Abstain 1,167.
  • Corporate name change amendment: For 21,100,143; Against 44,542; Abstain 12,407.
  • 2020 Equity Incentive Plan increase: For 13,079,270; Against 1,853,845; Abstain 17,401; Broker non-votes 6,206,576.
  • Nonbinding advisory vote on executive compensation: For 13,053,997; Against 1,887,562; Abstain 8,957; Broker non-votes 6,206,576.

Why It Matters

• Governance: The election results finalize the Company’s board makeup for the coming year and show varying levels of shareholder support for certain nominees (notably higher withheld votes for two directors).
• Auditor and name change: Ratifying the auditor ensures continuity of financial oversight; approval of a corporate name change may affect branding and disclosure going forward.
• Equity plan and compensation: Shareholder approval to increase the equity plan reserve allows the company to grant additional stock‑based awards, which can affect future dilution; the advisory “say-on-pay” was approved but is nonbinding.
• For investors: these are routine but material corporate governance actions that can influence dilution, management incentives, and corporate identity; monitor future filings for details on the name change implementation and any subsequent equity grants.